Apex Biotechnology Corp.
1733 TPE







Weekly Summary
Apex Biotechnology Corp. closed at 31.9000 (2.90% WoW) . Data window ends Mon, 22 Sep 2025.
How to read this — Price slope is upward, indicating persistent buying over the window. Volume trend diverges from price — watch for fatigue or rotation. Returns are positively correlated with volume — strength tends to arrive on higher activity. Distance to baseline is narrowing — reverting closer to its fair-value track. Price holds above key averages, indicating constructive participation.
Up-slope supports buying interest; pullbacks may be contained if activity stays firm. Because liquidity isn’t confirming, prefer evidence of fresh demand before chasing moves.
Gauge maps the trend signal to a 0–100 scale.
How to read this — Range-bound conditions; conviction is limited until a break or acceleration emerges.
Wait for a directional break or improving acceleration.

Relative strength is Negative
(< 0%, underperforming).
Latest MRS: -7.27% (week ending Fri, 19 Sep 2025).
Slope: Falling over 8w.
Notes:
- Below zero line indicates relative weakness vs benchmark.
- MRS slope falling over ~8 weeks.
The flag is positive: favourable upside skew with supportive conditions.
Conclusion
Positive setup. ★★★★☆ confidence. Trend: Range / Neutral · 7.05% over window · vol 2.27% · liquidity divergence · posture above · RS weak
- Price holds above 8–26 week averages
- Liquidity diverges from price
- Mansfield RS: weak & falling
Why: Price window 7.05% over w. Close is 1.92% above the prior-window high. Return volatility 2.27%. Volume trend falling. Liquidity divergence with price. Trend state range / neutral. Momentum neutral and rising. Valuation stance positive.
Tip: Most metrics include a hover tooltip where they appear in the report.